Sign in

CIK 0000849146 · Accelerated filer<br>Smaller reporting company

Lifevantage Corp

Sign in to watch
Ticker
LFVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
900224471
Phone
801-432-9000
Business address
3300 TRIUMPH BLVD, SUITE 700, LEHI, UT, 84043
Former names
LIFELINE THERAPEUTICS, INC., YAAK RIVER RESOURCES INC
Open-market buys, last 90 days
$6,071
in 1 filing
Open-market sales, last 90 days
$55,649
in 1 filing

Net −$49,578. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cunningham Kristen −$56K Chief Sales Officer sold 7% of stake
  2. Lewis Darwin +$6K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-08-31 Boyster Julie Chief Marketing Officer Option exercise +27,966 175,216
2025-08-31 Boyster Julie Chief Marketing Officer Shares withheld for taxes −23,293 $13.10 $305K 151,923
2025-08-31 Boyster Julie Chief Marketing Officer Option exercise · Performance Restricted Stock Units −18,934 6,312
2025-08-31 Boyster Julie Chief Marketing Officer Option exercise · Performance Restricted Stock Units −27,966 13,983
2025-08-26 Neufeld Alissa General Counsel Grant or award +9,036 100,605
2025-08-26 Neufeld Alissa General Counsel Grant or award · Performance Restricted Stock Units +13,554 13,554
2025-08-26 Boyster Julie Chief Marketing Officer Grant or award +13,102 128,316
2025-08-26 Boyster Julie Chief Marketing Officer Grant or award · Performance Restricted Stock Units +19,654 19,654
2025-08-26 Fife Steven R President and CEO Grant or award +48,193 659,500
2025-08-26 Fife Steven R President and CEO Grant or award · Performance Restricted Stock Units +72,289 72,289
2025-08-26 Cunningham Kristen Chief Sales Officer Grant or award +12,349 116,351
2025-08-26 Cunningham Kristen Chief Sales Officer Grant or award · Performance Restricted Stock Units +18,524 18,524
2025-08-26 Aure Carl Chief Financial Officer Grant or award +10,241 143,544
2025-08-26 Aure Carl Chief Financial Officer Grant or award · Performance Restricted Stock Units +15,361 15,361
2025-07-01 Aure Carl Chief Financial Officer Option exercise +2,401 136,049
2025-07-01 Aure Carl Chief Financial Officer Sale −2,746 $13.39 $37K 133,303
2025-07-01 Aure Carl Chief Financial Officer Option exercise · Performance Restricted Stock Units −2,401 0
2025-07-01 Fife Steven R President and CEO Shares withheld for taxes −21,064 $13.39 $282K 611,307
2025-07-01 Neufeld Alissa General Counsel Option exercise +2,667 94,368
2025-07-01 Neufeld Alissa General Counsel Shares withheld for taxes −2,799 $13.39 $37K 91,569

Page 5 of 10 · 193 trades